Somnera

somnera is a privately-held sleep solutions and connected health innovator focused on improving the lives of millions of patients suffering from obstructive sleep apnea (osa). the company secured its first fda clearance in 2018, followed by the clearance of its commercial-ready somnera™ system in june 2020. the somnera system is small, lightweight, and easy to use, ushering in a new era of sleep for osa patients. somnera’s technology is cloud-connected, enabling the latest advances in cloud-based data analytics, patient engagement, and automated reorder/subscription models. somnera holds 6 issued us patents, has completed two randomized clinical studies demonstrating equivalent effectiveness to cpap, and will launch in the us in october 2020. somnera’s dedicated and experienced management team is poised to capture share in the $35b available market for better osa therapies and provide outstanding return to its shareholders. for more information, or to be one of the first to own a somn